Join to view full profile
1860 Town Center Dr Ste 130Reston, VA 20190
Phone+1 703-689-2050
Fax+1 571-313-0231
Kelly Lee Mitchell is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Kelly Mitchell is a Physician Assistant specializing in Rheumatology, located in Reston, VA. She completed her education in 2015 at Nova Southeastern University.
She has a bachelor degree in Molecular, Cellular, Developmental Biology from the University of Colorado. She joined the Colorado School of Medicine Colorectal Cancer Research Team and investigated new chemotherapy agents. Kelly then transitioned to the University of Colorado Cancer Center and worked as a Clinical Trials Coordinator for Breast Cancer Clinical Trials.
After working with cancer patients, she pursued her Masters of Medical Science in Physicians Assistant Studies at NOVA Southeastern University in Fort Lauderdale. She graduated with highest honors at the top of her class. Kelly moved to Northern Virginia in 2015 and joined our practice shortly after. Kelly has a passion for autoimmune diseases and working with her patients to find the best individualized treatment plans. She takes real interest in osteoporosis and bone health as well as osteoarthritis.
Certifications & Licensure
National Commission on Certification of Physician Assistants (NCCPA) Certified Physician Assistant
Education & Training
Nova Southeastern UniversityPhysician Assistant, 2015
Professional Memberships
- Member
- Member
- American College of RheumatologyMember
- The Virginia Society of RheumatologyMember
Publications & Presentations
PubMed
- 29 citationsAntitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer.Todd M. Pitts, Erica L. Bradshaw-Pierce, Stacey M. Bagby, Stephanie L. Hyatt, Heather M. Selby
Oncotarget. 2016-07-01 - 58 citationsRational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal CancerAnna Spreafico, John J. Tentler, Todd M. Pitts, Aik Choon Tan, Mark A. Gregory
Clinical Cancer Research. 2013-08-01 - 33 citationsAssociation of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer modelsTodd M. Pitts, Gillian N. Kulikowski, Aik Choon Tan, Brion W. Murray, John J. Arcaroli
Frontiers in Pharmacology. 2013-03-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
